These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 372232)

  • 21. Effect of gamma radiation on Serratia marcescens. Studies on the radiosensitivity of prodigiosin production.
    Bartlett WT; O'Donovan GA; Neff RD
    Radiat Res; 1970 Jul; 43(1):196-203. PubMed ID: 4914161
    [No Abstract]   [Full Text] [Related]  

  • 22. Nosocomial outbreak of nitrate-negative Serratia marcescens infections.
    Geiseler PJ; Harris B; Andersen BR
    J Clin Microbiol; 1982 Apr; 15(4):728-30. PubMed ID: 7040469
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New prodigiosin-like pigment from Alteromonas rubra.
    Gerber NN; Gauthier MJ
    Appl Environ Microbiol; 1979 Jun; 37(6):1176-9. PubMed ID: 384909
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Various physiological aspects of Serratia marcescens pigmented strains and their pigmentless variants with an elevated nuclease activity].
    Porfir'eva OV; Iusupova DV; Beliaeva MI
    Mikrobiologiia; 1976; 45(6):1045-8. PubMed ID: 189164
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipid content of antibiotic-resistant and -sensitive strains of Serratia marcescens.
    Chang CY; Molar RE; Tsang JC
    Appl Microbiol; 1972 Dec; 24(6):972-6. PubMed ID: 4568257
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prodigiosin and the metabolism of free amino compounds in Serratia marcescens as a function of iron, manganese, and aging.
    Reisner GS
    Can J Microbiol; 1969 May; 15(5):405-8. PubMed ID: 4891884
    [No Abstract]   [Full Text] [Related]  

  • 27. Continued surveillance of Serratia marcescens infections by bacteriocin typing: investigation of two outbreaks of cross-infection in an intensive care unit.
    Traub WH
    Appl Microbiol; 1972 May; 23(5):982-5. PubMed ID: 4555641
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quinolone resistance in clinical isolates of Serratia marcescens.
    Fujimaki K; Fujii T; Aoyama H; Sato K; Inoue Y; Inoue M; Mitsuhashi S
    Antimicrob Agents Chemother; 1989 May; 33(5):785-7. PubMed ID: 2546493
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Changes effected in "Serratia marcescens" from treatment with eritrocina (author's transl)].
    Cerbo M; Vecchione R
    Ann Sclavo; 1978; 20(3):312-7. PubMed ID: 367293
    [No Abstract]   [Full Text] [Related]  

  • 30. [The effect of the cultivation conditions on the growth and pigmentation of Serratia marcescens].
    Andreeva IN; Ogorodnikova TI
    Zh Mikrobiol Epidemiol Immunobiol; 1999; (3):16-20. PubMed ID: 10851983
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biotyping of Serratia marcescens and its use in epidemiological studies.
    Grimont PA; Grimont F
    J Clin Microbiol; 1978 Jul; 8(1):73-83. PubMed ID: 353073
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fatty acid profiles in pigmented and non-pigmented strains of S. marcescens.
    Pizzimenti FC; Nostro A; Marino A; Villari A; Verzera A; Trozzi A; Alonzo V
    New Microbiol; 1999 Apr; 22(2):91-8. PubMed ID: 10322607
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidemiological differentiation of Serratia marcescens: typing by bacteriocin production.
    Farmer JJ
    Appl Microbiol; 1972 Feb; 23(2):218-25. PubMed ID: 4552884
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decrease in respiration activity related to prodigiosin synthesis in Serratia marcescens.
    Kobayashi N; Ichikawa Y
    Microbiol Immunol; 1985; 29(4):301-8. PubMed ID: 3894888
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of a red-pigmented bacterium producing a potent anti-tumor N-alkylated prodigiosin as Serratia marcescens.
    Deorukhkar AA; Chander R; Ghosh SB; Sainis KB
    Res Microbiol; 2007 Jun; 158(5):399-404. PubMed ID: 17467243
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolic and regulatory engineering of Serratia marcescens: mimicking phage-mediated horizontal acquisition of antibiotic biosynthesis and quorum-sensing capacities.
    Coulthurst SJ; Williamson NR; Harris AKP; Spring DR; Salmond GPC
    Microbiology (Reading); 2006 Jul; 152(Pt 7):1899-1911. PubMed ID: 16804166
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of fibrinolytic and elastase activity among clinical isolates of Serratia marcescens.
    Traub WH; Kleber I
    Pathol Microbiol (Basel); 1974; 41(6):334-40. PubMed ID: 4375799
    [No Abstract]   [Full Text] [Related]  

  • 38. Epidemic outbreak of Serratia marcescens infection in a cardiac surgery unit.
    Wilhelmi I; Bernaldo de Quirós JC; Romero-Vivas J; Duarte J; Rojo E; Bouza E
    J Clin Microbiol; 1987 Jul; 25(7):1298-300. PubMed ID: 3301892
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distribution and Genetic Diversity of Genes Involved in Quorum Sensing and Prodigiosin Biosynthesis in the Complete Genome Sequences of Serratia marcescens.
    Sakuraoka R; Suzuki T; Morohoshi T
    Genome Biol Evol; 2019 Mar; 11(3):931-936. PubMed ID: 30840067
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition by streptomycin of the biosynthesis of prodigiosin.
    Williams RP; Gott CL
    Biochem Biophys Res Commun; 1964 May; 16(1):47-52. PubMed ID: 5332843
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.